Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication

Human Gene Therapy

Volumn 11, Issue 1, 2000, Pages 53-65

  Economou, J S ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c Department of Surgery ^*  (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; RECOMBINANT INTERLEUKIN 7; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE THERAPY; IMMUNE RESPONSE; LUNG CANCER; MOUSE; NONHUMAN;

EID: 84941944867     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050016157     Document Type: Article

References (47)

1. Akashi, K., Kondo, M., Von Freeden-Jeffry, U., Murray, R., and Weissman, I. (1997). Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89, 1033-1041.
2. Alters, S., Gadea, J., Sorich, M., O'Donoghue, G., Talib, S., and Philip, R. (1998). Dendritic cells pulsed with CEA peptide induce CEA-specific CTL with restricted TCR repertoire. J. Immunother. 21, 17-26.
3. Arthur, J., Butterfield, L., Roth, M., Bui, L., Kiertscher, S., Lau, R., Dubinett, S., Glaspy, J., Mcbride, W., and Economou, J. (1997). A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther. 4, 17-25.
4. Banchereau, J., and Steinman, R.M. (1998). Dendritic cells and the control of immunity. Nature (London) 392, 245-252.
5. Barratt-Boyes, S., Watkins, S., and Finn, O. (1997). In vivo migration of dendritic cells differentiated in vitro: a chimpanzee model. J. Immunol. 158, 4543-4547.
6. Bevan, M.J. (1995). Antigen presentation to cytotoxic T lymphocytes in vivo. J. Exp. Med. 182, 639-641.
7. Brossart, P., Goldrath, A., Butz, E., Martin, S., and Bevan, M. (1997). Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J. Immunol. 158, 3270-3276.
8. Boczkowski, D., Nair, S., Snyder, D., and Gilboa, E. (1996). Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184, 465-472.
9. Butz, E., and Bevan, M. (1998). Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 8, 167-175.
10. Celluzzi, C., and Falo, L.J. (1998). Cutting edge: Physical interaction between dendritic cells and tumor cells result in an immunogen that induces protective and therapeutic tumor rejection. J. Immunol. 160, 3081-3085.
11. Celluzzi, C.M., Mayordomo, J.I., Storkus, W.J., Lotze, M.T., and Falo, L.D., Jr. (1996). Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183, 283-287.
12. Dubinett, S.M., Huang, M., Dhanani, S., Wang, J., and Beroiza, T. (1993). Down-regulation of macrophage transforming growth factor-β messenger RNA expression by interleukin-7. J. Immunol. 151, 6670-6680.
13. Dubinett, S.M., Miller, P.W., Sharma, S., and Batra, R.K. (1998). Gene therapy for lung cancer. Hematol. Oncol. Clin. North Am. 12, 569-594.
14. Fields, R.C., Shimizu, K., and Mule, J.J. (1998). Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 95, 9482-9487.
15. Gabrilovich. D.I., Chen, H.L., Girgis, K.R., Cunningham, H.T., Meny, G.M., Nadaf, S., Kavanaugh, D., and Carbone, D.P. (1996). Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Med. 2, 1096-1103.
16. Gambotto, A., Tuting, T., McVey, D., Kovesdi, I., Tahara, H., Lotze, M., and Robbins, P. (1999). Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12. Cancer Gene Ther. 6, 45-53.
17. Gong, J., Chen, D., Kashiwara, M., and Kufe, D. (1997). Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nature Med. 3, 558-561.
18. Huang, A.Y.C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., and Levitsky, H. (1994). Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264, 961-965.
19. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., Kos, R.M., and Steinman, R. (1992). Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophages colony-stimulated factor. J. Exp. Med. 176, 1693-1702.
20. Kos, F.J., and Mullbacher, A. (1993). IL-2-independent activity of IL-7 in the generation of secondary antigen-specific cytotoxic T cell responses in vitro. J. Immunol. 150, 387-393.
21. Kronin, V., Winkel, K., Suss, G., Kelso, A., Heath, W., Kirberg, J., Von Boehmer, H., and Shortman, K. (1996). A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J. Immunol. 157, 3819-3827.
22. Lynch, D.H., and Miller, R.E. (1994). Interleukin 7 promotes longterm in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo. J. Exp. Med. 179, 31-42.
23. Malave, I., Blanca, I., and Fuji, H. (1979). Influence of inoculation site on development of the Lewis lung carcinoma and suppressor cell activity in syngeneic mice. J. Natl. Cancer Inst. 62, 83-88.
24. Mandelboim, O., Berke, G., Fridkin, M., Feldman, M., Eisenstein, M., and Eisenbach, L. (1994). CTL induction by a tumor-associated antigen octapeptide derived from a murine lung carcinoma. Nature (London) 369, 67-71.
25. Mandelboim, O., Vadai, E., Fridkin, M., Katz-Hillel, A., Feldman, M., Berke, G., and Eisenbach, L. (1995). Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides. Nature Med. 1, 1179-1183.
26. Mayordomo, J.I., Zorina, T., Storkus, W.J., Zitvogel, L., Celluzzi, C., Falo, L.D., Melief, C.J., Ildstad, S.T., Kast, W.M., Deleo, A.B., and Lotze, M.T. (1995). Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nature Med. 1, 1297-1302.
27. McBride, W.H., Thacker, J.D., Comora, S., Economou, J., Kelley, D., Dubinett, S.M., and Dougherty, G.J. (1992). Genetic modification of a murine fibrosarcomato produce IL-7 stimulates host cell infiltration and tumor immunity. Cancer Res. 52, 3931-3937.
28. Mehrotra, P.T., Grant, A.J., and Siegel, J.P. (1995). Synergistic effects of IL-7 and IL-12 on human T cell activation. J. Immunol. 154, 5093-5102.
29. Miller, A.R., McBride, W.H., Dubinett, S.M., Dougherty, G.J., Thacker, J.D., Shau, H., Kohn, D.B., Moen, R.C., Walker, M.J., Chiu, R., Schuck, B.L., Rosenblatt, J.A., Huang, M., Dhanani, S., Rhoades, K., and Economou, J.S. (1993). Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: Comparison of immunological properties with IL-2. Blood 82, 3686-3694.
30. Miller, P.W., Sharma, S., Stolina M., Chen, K., Zhu, L., Paul, R.W., and Dubinett, S.M. (1998). Dendritic cells augment granulocyte-macrophage colony-stimulating factor (GM-CSF)/herpes simplex virus thymidine kinase-mediated gene therapy of lung cancer. Cancer Gene Ther. 5, 380-389.
31. Nestle, F., Alijagic S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., and Schadendorf, D. (1998). Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nature Med. 4, 328-332.
32. Overwijk, W.W., Lee, D.S., Surman, D.R., Irvine, K.R., Touloukian, C.E., Chan, C.C., Carroll, M.W., Moss, B., Rosenberg, S.A., and Restifo, N.P. (1999). Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 96, 2982-2987.
33. Ribas, A., Butterfield, L., McBride, W., Jilani, S., Bui, L., Vollmer, C., Lau, R., Dissette, V., Hu, B., Chen, A., Glaspy, J., and Economou, J. (1997). Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res. 57, 2865-2869.
34. Sallusto, F., Cella, M., Danieli, C., and Lanzavecchia, A. (1995). Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400.
35. Schwartzentruber, D., Stetler-Stevenson, M., Rosenberg, S., and Topalian, S. (1993). Tumor-infiltrating lymphocytes derived from select B-cell lymphomas secrete granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha in response to autologous tumor stimulation. Blood 82, 1204-1211.
36. Sharma, S., Miller, P., Stolina, M., Zhu, L., Huang, M., Paul, R., and Dubinett, S. (1997). Multicomponent gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin 7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo-activated dendritic cells. Gene Ther. 4, 1361-1370.
37. Sharma, S., Wang, J., Huang, M., Paul, R., Lee, P., McBride, W., Economou, J., Roth, M., Kiertscher, S., and Dubinett, S. (1996). Interleukin-7 gene transfer in non-small cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity. Cancer Gene Ther. 3, 302-313.
38. Steinman, R. (1991). The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271-296.
39. Tjoa, B.A., Simmons, S.J., Elgamal, A., Rogers, M., Ragde, H., Kenny, G.M., Troychak, M.J., Boynton, A.L., and Murphy, G.P. (1999). Follow-up evaluation of a phase II prostate cancer vaccine trial. Prostate 40, 125-129.
40. Toes, R.E., Hoeben, R.C., Van Der Voort, E.I., Ressing, M.E., Van Der Eb, A.J., Melief, C.J., and Offringa, R. (1997). Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion. Proc. Natl. Acad. Sci. U.S.A. 94, 14660-14665.
41. Toes, R., Van Der Voort, E., Schoenberger, S., Drijfhout, J., Van Bloois, L., Storm, G., Kast, W., Offringa, R., and Melief, C. (1998). Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J. Immunol. 160, 4449-4456.
42. Waldrop, S., Pitcher, C., Peterson, D., Maino, V., and Picker, L. (1997). Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry. J. Clin. Invest. 99, 1739-1750.
43. Yang, Y., Li, Q., Ertl, H., and Wilson, J. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
44. Yang, Y., Nunes, F.A., Berenesi, K., Furth, E.E., Gönczöl, E., and Wilson, J.M. (1994). Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 91, 4407-4411.
45. Yei, S., Mittereder, N., Tang, K., O'Sullivan, C, and Trapnell, B.C. (1994). Adenovirus-mediated gene transfer for cystic fibrosis: Quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1, 192-200.
46. Yuhas, J., Toya, R., and Wagner, E. (1975). Specific and nonspecific stimulation of resistance to the growth and metastasis of the line 1 lung carcinoma. Cancer Res. 35, 242.
47. Zitvogel, L., Mayordomo, J.I., Tjandrawan, T., Deleo, A.B., Clarke, M.R., Lotze, M.T., and Storkus, W.J. (1996). Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183, 87-97.